A phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps

BACKGROUND: Topical intranasal corticosteroid sprays (INCSs) are standard treatment for nasal polyps (NPs), but their efficacy is reduced by poor patient compliance and impaired access of drug to the sinus mucosa. A corticosteroid‐eluting sinus implant was designed to address these limitations in pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Kern, Robert C., Stolovitzky, J. Pablo, Silvers, Stacey L., Singh, Ameet, Lee, Jivianne T., Yen, David M., Iloreta, Alfred M.C., Langford, Francis P.J., Karanfilov, Boris, Matheny, Keith E., Stambaugh, James W., Gawlicka, Anna K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900893/
https://www.ncbi.nlm.nih.gov/pubmed/29350840
http://dx.doi.org/10.1002/alr.22084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5900893/
https://www.ncbi.nlm.nih.gov/pubmed/29350840
http://dx.doi.org/10.1002/alr.22084

Ejemplares similares